[앵커]
However, there are some European countries that have temporarily stopped using the AstraZeneca vaccine. This is a preventive measure because there have been cases of death from blood clots after getting this vaccine in Italy and Den Mart. The European Medicines Agency stressed that the vaccine could be given while the investigation was under way, saying the exact cause-and-effect relationship has not yet been established.
This is reporter Kang Willow.
[기자]
[도미닉 라브/영국 외무장관 : 영국은 그(아스트라제네카) 백신을 맞아도 안전하다고 확신합니다.]
[올리비에 베랑/프랑스 보건장관 : 백신 접종에 따른 위험과 이득을 따졌을 때, 이득이 더 큽니다.]
[옌스 슈판/독일 보건장관 : 유럽 대부분의 나라들처럼 우리도 아스트라제네카 백신 접종을 계속할 계획입니다.]
On the 11th of local time, authorities in Britain, Germany and France defended the AstraZeneca vaccine.
When the Danish and Norwegian governments announced that they would temporarily suspend the use of the AstraZeneca vaccine, citing a case of death due to blood clots after vaccination, they feared that the atmosphere would be avoided.
Austria also said on the 7th that a woman in her 40s died of a severe coagulation disorder after vaccination with the AstraZeneca vaccine.
Another problem in Denmark is a vaccine manufactured in the same process as in Austria.
Although the manufacturing unit is different, Italy has also temporarily stopped vaccination, saying that two cases of death have been reported after vaccination with the AstraZeneca vaccination.
Investigation is ongoing, but a link between death and vaccine has not yet been confirmed.
The European Medicines Agency, as well as countries that have stopped vaccination, say,’There is currently no indication that the vaccine caused blood clots’.
(Video Design: Seonghyun Park)